Sung Jun Park

Company: Hanmi Fine Chemical

Job title: Team Lead

Seminars:

HanmiCap: Advancing mRNA Therapeutics with Innovative Cap Analogs 3:50 pm

Introducing novel 5′ cap analogs featuring m7GpppA modifications that enhance mRNA translation efficiency and reduce dsRNA levels, delivering superior outcomes in mRNA therapeutics Its highly efficient manufacturing process enables large-scale, high-purity production at significantly lower cost, providing a clear cost-down advantage for both mRNA research and commercial applications Hanmi Fine Chemical leverages its CDMO expertise…Read more

day: Conference Day One